Aktis Oncology, Inc. (AKTS)

19.20 +0.30 (+1.59%) USD  |  NASDAQ  |  Feb 23, 14:51
More

Aktis Oncology Buy Recommendations

Buy Recommendations Chart

View Buy Recommendations for AKTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Buy Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Buy Recommendations Range, Past 5 Years

View Buy Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Buy Recommendations Benchmarks

View Buy Recommendations Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Akari Therapeutics Plc Upgrade
Alumis, Inc. Upgrade
Medline, Inc. Upgrade